Seamless CDMO solutions
With the number of registered clinical trials increasing significantly each year, it’s not surprising to learn that the clinical trials supply and logistics market is predicted to...
Cutting edge fill-finish solutions
Utilising the latest advancements of the Microcell and SA25 technologies, PCI Pharma Services delivers flexible aseptic fill-finish solutions for both small and larger-scale...
Biologics and Specialty Medicines: Planning Your Packaging for a Seamless Transition from Clinic to Launch
The pharmaceutical landscape continues to evolve with an ever-increasing focus on specialty medicines. As a result, supply chains are becoming more complex, driven by factors such as...
Planning for Return and Destruction
Annex I, states that a clinical protocol shall include “a description of the arrangements for tracing, storing, destroying and returning the investigational medicinal product...
Why Robotic Sterile Fill-Finish is Key for Speed to Clinic and Patient Safety
Sterile fill-finish is a mainstay in pharmaceutical manufacturing, and robotic platforms will be a true differentiator. This latest article from PCI discusses robotic sterile...
Product return and destruction
Executive Q&A on Driving Digital Transformation in the Pharma Industry
As a respected industry leader and trusted partner, PCI Pharma Services provides a comprehensive range of pharmaceutical services from the earliest stages of drug development through...
Navigating the New EU Clinical Trial Regulation
PCI Clinical Trial Services hosts a weekly “Virtual Water Cooler Chat” series, where our subject matter experts host informal discussions around a number of clinical supply “hot topics.”
Delivering the Full Value Chain for Oncology Clinical Trials
The incidence of cancer is increasing across the globe, and pharmaceutical companies are responding with a pipeline of novel therapeutic candidates. Oncology clinical trials are...
An Evolving Biologics Landscape and Driving Innovation and Opportunity
The biologics segment, already growing in importance before the COVID-19 pandemic, is expanding even faster in its wake with respect to both the level of investment and number of...
A game-changing digital platform
The pharmaceutical industry has historically been risk-averse and slow to adopt technology. PCI Pharma Services is blazing a trail in digitalisation.
Precision micro-dosing for clinical development
A game-changing digital platform
Adaptive drug supply
There are many factors that can derail trials, which is why adaptive clinical trial designs are a good solution to allow for unforeseen data results. It is clinical trial...
PCI_Importing Clinical Supplies into China
PCI-Clinical-Trial-Services-March-20
PCI The Final Mile for European Compassionate Use Programs
